Royce & Associates’s Vapotherm, Inc. Common Stock VAPO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-18,138
Closed -$3.48M 1055
2021
Q1
$3.48M Buy
+18,138
New +$4.21M 0.02% 669

Other funds holding VAPO

Royce & Associates's VAPO Position: Q2 2021 in Review

Royce & Associates sold out of Vapotherm, Inc. Common Stock (VAPO) in Q2 2021, closing a stake of 18,138 shares — an estimated $3.48M sold.

Royce & Associates first reported a position in VAPO in Q1 2021 and held it in 1 quarter. The position peaked at $3.48M in Q1 2021. 89 funds tracked by Wall St. Rank hold VAPO as of Q2 2021.

  • Royce & Associates reported no remaining Vapotherm, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Royce & Associates sold 18,138 Vapotherm, Inc. Common Stock shares in Q2 2021, an estimated $3.48M.
  • Royce & Associates first reported a position in Vapotherm, Inc. Common Stock in Q1 2021 and held it in 1 quarter.
  • Royce & Associates's Vapotherm, Inc. Common Stock position peaked at $3.48M in Q1 2021.
  • 89 funds tracked by Wall St. Rank held Vapotherm, Inc. Common Stock as of Q2 2021.

Based on Royce & Associates's 13F filing for Q2 2021, filed 6 Aug 2021.